tradingkey.logo


tradingkey.logo


Avanos Medical Inc

AVNS
13.520USD
-0.310-2.24%
āļ›āļīāļ” 03/27, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
628.87MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Avanos Medical Inc āļšāļĢāļīāļĐāļąāļ—

Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.

āļ‚āđ‰āļ­āļĄāļđāļĨ Avanos Medical Inc


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™AVNS
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Avanos Medical Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 21, 2014
āļ‹āļĩāļ­āļĩāđ‚āļ­Pacitti (David)
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™2227
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“Oct 21
āļ—āļĩāđˆāļ­āļĒāļđāđˆ5405 Windward Parkway
āđ€āļĄāļ·āļ­āļ‡ALPHARETTA
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNASDAQ OMX NASDAQ Basic NYSE
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ30004
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ18444282667
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://avanos.com/
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™AVNS
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļOct 21, 2014
āļ‹āļĩāļ­āļĩāđ‚āļ­Pacitti (David)

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Avanos Medical Inc


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
585.43K
+17.31%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
131.59K
+30.40%
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
80.43K
+19.75%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Vice President - Corporate Finance, Treasurer
Vice President - Corporate Finance, Treasurer
--
--
Ms. Camille Chang Gilmore
Ms. Camille Chang Gilmore
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
--
--
Mr. Scott Galovan
Mr. Scott Galovan
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer, Director
Chief Executive Officer, Director
585.43K
+17.31%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
131.59K
+30.40%
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
80.43K
+19.75%
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Digestive Health
114.00M
65.90%
Pain Management
59.00M
34.10%
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„USD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
North America
135.80M
78.50%
Europe, Middle East and Africa
28.70M
16.59%
Asia Pacific and Latin America
13.30M
7.69%
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Digestive Health
114.00M
65.90%
Pain Management
59.00M
34.10%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļĄāļĩ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 20 āļĄāļĩ.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.26%
T. Rowe Price Investment Management, Inc.
9.61%
The Vanguard Group, Inc.
7.42%
Armistice Capital LLC
6.88%
Dimensional Fund Advisors, L.P.
4.64%
āļ­āļ·āđˆāļ™ āđ†
58.19%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
BlackRock Institutional Trust Company, N.A.
13.26%
T. Rowe Price Investment Management, Inc.
9.61%
The Vanguard Group, Inc.
7.42%
Armistice Capital LLC
6.88%
Dimensional Fund Advisors, L.P.
4.64%
āļ­āļ·āđˆāļ™ āđ†
58.19%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
45.78%
Investment Advisor/Hedge Fund
29.12%
Hedge Fund
17.63%
Individual Investor
4.88%
Research Firm
2.99%
Family Office
2.13%
Pension Fund
1.30%
Bank and Trust
0.45%
Insurance Company
0.03%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļˆāļąāļ™āļ—āļĢāđŒāļ—āļĩāđˆ 8 āļ˜.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q4
599
44.88M
113.89%
+5.76K
2025Q3
617
45.01M
114.39%
-81.05K
2025Q2
610
45.14M
115.30%
+1.07M
2025Q1
615
44.04M
105.94%
-4.70M
2024Q4
596
44.47M
105.92%
+325.84K
2024Q3
583
44.12M
104.92%
+568.23K
2024Q2
585
43.69M
107.04%
-931.37K
2024Q1
593
44.72M
107.68%
-5.03M
2023Q4
601
45.14M
107.42%
+359.77K
2023Q3
598
44.92M
104.35%
-994.38K
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
BlackRock Institutional Trust Company, N.A.
6.15M
13.24%
-83.66K
-1.34%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
4.71M
10.15%
+716.98K
+17.94%
Sep 30, 2025
The Vanguard Group, Inc.
3.36M
7.24%
-1.04M
-23.62%
Sep 30, 2025
Armistice Capital LLC
2.50M
5.39%
+464.00K
+22.79%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.35M
5.07%
-225.43K
-8.74%
Sep 30, 2025
State Street Investment Management (US)
1.90M
4.1%
-16.26K
-0.85%
Sep 30, 2025
Brown Advisory
2.23M
4.8%
+417.92K
+23.10%
Sep 30, 2025
D. E. Shaw & Co., L.P.
1.30M
2.8%
+107.12K
+8.99%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.07M
2.3%
-6.53K
-0.61%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
863.95K
1.86%
+199.41K
+30.01%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 6 āļ˜.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
State Street SPDR S&P Health Care Equipment ETF
0.8%
Invesco S&P SmallCap 600 Pure Value ETF
0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.37%
Invesco S&P SmallCap Health Care ETF
0.32%
Royce Quant Small-Cap Quality Value ETF
0.31%
Harbor Human Capital Factor US Small Cap ETF
0.22%
Vanguard US Value Factor ETF
0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.13%
Fidelity Enhanced Small Cap ETF
0.13%
Pacer US Small Cap Cash Cows ETF
0.09%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
State Street SPDR S&P Health Care Equipment ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.8%
Invesco S&P SmallCap 600 Pure Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.43%
Pacer US Small Cap Cash Cows Growth Leaders ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.37%
Invesco S&P SmallCap Health Care ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.32%
Royce Quant Small-Cap Quality Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.31%
Harbor Human Capital Factor US Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.22%
Vanguard US Value Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.15%
SPDR SSGA US Small Cap Low Volatility Index ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.13%
Fidelity Enhanced Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.13%
Pacer US Small Cap Cash Cows ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.09%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™